← Back
Data updated: Mar 29, 2026
BEIGENE
OncologyGastroenterologyImmunology
Biotech
BEIGENE is a biotechnology company focused on Oncology, Gastroenterology, Immunology.
2024
Since
1
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 89%
1 drugs Phase 3: 22 Phase 2: 36 Phase 1: 45
Gastroenterology 8%
1 drugs Phase 3: 1 Phase 2: 2 Phase 1: 5
Immunology 2%
0 drugs Phase 2: 2 Phase 1: 1
Respiratory 1%
0 drugs Phase 2: 1
Dermatology 0%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
Novartis big-pharma
Oncology, Immunology, Respiratory
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology, Respiratory
MALLINCKRODT specialty
Gastroenterology, Dermatology, Immunology, Respiratory
GSK big-pharma
Respiratory, Oncology, Immunology
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-03-13
- Latest
- 2025-12-09
- Applications
- 3